Novel engineered chimeric engulfment receptors trigger T cell effector functions against SIV-infected CD4+ T cells: Molecular Therapy - Methods & Clinical Development
Por um escritor misterioso
Descrição
Inhibition of HIV-1 release by TIMs. TIM-1, 3, and 4 trap HIV-1 on the
Quantitative Control of Gene-Engineered T-Cell Activity through the Covalent Attachment of Targeting Ligands to a Universal Immune Receptor
Meeting FDA Guidance recommendations for replication-competent virus and insertional oncogenesis testing: Molecular Therapy - Methods & Clinical Development
Engineering and Design of Chimeric Antigen Receptors: Molecular Therapy - Methods & Clinical Development
Immune inactivation of anti-simian immunodeficiency virus chimeric antigen receptor T cells in rhesus macaques. - Abstract - Europe PMC
Frontiers Chimeric antigen receptor T cells applied to solid tumors
Deciphering CD4+ T cell specificity using novel MHC–TCR chimeric receptors
Immune inactivation of anti-simian immunodeficiency virus chimeric antigen receptor T cells in rhesus macaques. - Abstract - Europe PMC
Issue: Molecular Therapy - Methods & Clinical Development
Real-Time Killing Assays to Assess the Potency of a New Anti-Simian Immunodeficiency Virus Chimeric Antigen Receptor T Cell
Construct design, and expression in rhesus macaque T cells. (a)
de
por adulto (o preço varia de acordo com o tamanho do grupo)